The incorporation of radiation therapy alongside the inhibition of the PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) pathways exhibited certain efficacy in patients with resistant CRC, who have historically shown limited response to simultaneous PD-1 and CTLA4 pathway inhibition [76]. Here, PDCD1 is linked to colorectal carcinoma.